Afatinib, Dose Reduction, and Pseudo-Acute Kidney Injury | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
#lcsm #oncmeded #ClinicalDilemna
#lcsm #oncmeded #ClinicalDilemna
Afatinib, Dose Reduction, and Pseudo-Acute Kidney Injury
ascopubs.org
July 25, 2025 at 1:38 AM
Everybody can reply
1 likes